Document Classification

Section Type: RESULTS

Text: Combination of bevacizumab 15 mg/kg, but not 7. 5 mg/kg, with docetaxel showed superior median PFS (mPFS) to placebo plus docetaxel in unstratified analysis (placebo mPFS, 8. 2 months ; 7. 5 mg/kg mPFS, 9. 0 months [hazard ratio (HR), 0. 86 ; P =. 12] ; 15 mg/kg mPFS, 10. 1 months [HR, 0. 77 ; P =. 006]) and stratified analysis (placebo mPFS, 8. 1 months ; 7. 5 mg/kg mPFS, 9. 0 months [HR, 0. 80 ; P =. 045] ; 15 mg/kg mPFS, 10. 0 months [HR, 0. 67 ; P <. 001]).